RIMASSA, Lorenza

RIMASSA, Lorenza  

Dipartimento Scienze Biomediche  

Mostra records
Risultati 1 - 20 di 278 (tempo di esecuzione: 0.024 secondi).
Titolo Data di pubblicazione Autore(i) File
18F-FDG PET and CT scan in the pre-operative evaluation of colorectal liver metastases treated with chemotherapy 1-gen-2006 Rimassa, L.; Chiti, A.; Carnaghi, C.; Doci, R.; Torzilli, G; Zuradelli, M.; Tondulli, L.; Pressiani, T.; Lutman, F. R.; Tronconi, M. C.; Santoro, A.
18F-FDG pet does not improve contrast enhanced CT scan sensitivity in the evaluation of liver metastases after chemotherapy 1-gen-2006 Carnaghi, Carlo; Chiti, Arturo; Rimassa, Lorenza; Zuradelli, Monica; Tondulli, Luca; Torzilli, G; Doci, Roberto; Tronconi Maria, Chiara; Pressiani, Tiziana; Santoro, Armando
5-fluorouracil, dacarbazine, and epirubicin in the treatment of patients with neuroendocrine tumors 1-gen-1998 Bajetta, E; Rimassa, L; Carnaghi, C; Seregni, E; Ferrari, L; Di Bartolomeo, M; Regalia, E; Cassata, A; Procopio, G; Mariani, L
A new nomogram for estimating survival in patients with brain metastases secondary to colorectal cancer 1-gen-2015 Pietrantonio, F; Aprile, G; Rimassa, L; Franco, P; Lonardi, S; Cremolini, C; Biondani, P; Sbicego, El; Pasqualetti, F; Tomasello, G; Niger, M; Casagrande, M; Ghidini, M; Muni, R; Montrone, S; Bergamo, F; Berenato, R; Fontanella, C; Bozzarelli, S; Moretto, R; Battaglin, F; Di Bartolomeo, M; de Braud, F; Miceli, R
A randomized, multicenter, phase II study of vandetanib monotherapy versus vandetanib in combination with gemcitabine versus gemcitabine plus placebo in subjects with advanced biliary tract cancer: the VanGogh study 1-gen-2015 Santoro, A; Gebbia, V; Pressiani, T; Testa, A; Personeni, N; Bajardi, Ea; Foa, P; Buonadonna, A; Bencardino, K; Barone, C; Ferrari, D; Zaniboni, A; Tronconi, Mc; Carteni, G; Milella, M; Comandone, A; Ferrari, S; Rimassa, L
Activity and safety of NGR-hTNF, a selective vascular-targeting agent, in previously treated patients with advanced hepatocellular carcinoma 1-gen-2010 Santoro, A; Pressiani, T; Citterio, G; Rossoni, G; Donadoni, G; Pozzi, F; Rimassa, L; Personeni, N; Bozzarelli, S; Rossoni, G; Colombi, S; De Braud, Fg; Caligaris-Cappio, F; Lambiase, A; Bordignon, C
Adjuvant Treatment of High-Risk, Radically Resected Gastric Cancer Patients With 5-Fluorouracil, Leucovorin, Cisplatin, and Epidoxorubicin in a Randomized Controlled Trial. 1-gen-2007 Cascinu, S; Labianca, R; Barone, C; Santoro, A; Carnaghi, C; Cassano, A; Beretta, Gd; Catalano, V; Bertetto, O; Barni, S; Frontini, L; Aitini, E; Rota, S; Torri, V; Floriani, I; Italian Group for the Study of Digestive Tract, Cancer; Pozzo, C; Rimassa, L; Mosconi, S; Giordani, P; Ardizzoia, A; Foa, P; Rabbi, C; Chiara, S; Gasparini, G; Nardi, M; Mansutti, M; Arnoldi, E; Piazza, E; Cortesi, E; Pucci, F; Silva, Rr; Sobrero, A; Ravaioli, A
Adrenal metastases from adenocarcinoma of the esophagogastric junction: adrenalectomy and long-term survival. 1-gen-2010 Fumagalli, U; de Carli, S; de Pascale, S; Rimassa, L; Bignardi, M; Rosati, R
Aggressive and Multidisciplinary Local Approach to Iterative Recurrences of Colorectal Liver Metastases 1-gen-2018 Vigano, L; Pedicini, V; Comito, T; Carnaghi, C; Costa, G; Poretti, D; Franzese, C; Personeni, N; Del Fabbro, D; Rimassa, L; Scorsetti, M; Santoro, A; Solbiati, L; Torzilli, G
The ALBI grade: evidence for an improved model for liver functional estimation in patients with hepatocellular carcinoma 1-gen-2021 Demirtas, Coskun O.; D’Alessio, Antonio; Rimassa, Lorenza; Sharma, Rohini; Pinato, David J.
Alpha-fetoprotein screening in patients with hepatitis C-induced cirrhosis who achieved a sustained virologic response in the direct-acting antiviral agents era 1-gen-2018 Spadaccini, M; Lleo, A; Ceriani, R; Covini, G; Rimassa, L; Torzilli, G; Di Tommaso, L; Aghemo, A
Angiogenesis inhibitors for advanced hepatocellular carcinoma: in search for the right partner 1-gen-2020 Campani, Claudia; Rimassa, Lorenza; Personeni, Nicola; Marra, Fabio
Antacid exposure and immunotherapy outcomes among patients with advanced hepatocellular carcinoma 1-gen-2021 Jun, Tomi; Ozbek, Umut; Dharmapuri, Sirish; Hardy-Abeloos, Camille; Zhu, Huili; Lin, Jung-Yi; Personeni, Nicola; Pressiani, Tiziana; Nishida, Naoshi; Lee, Pei-Chang; Lee, Chieh-Ju; Hildebrand, Hannah; Nimkar, Neil; Paul, Sonal; Fessas, Petros; Naeem, Muntaha; Bettinger, Dominik; Khan, Uqba; Saeed, Anwaar; Huang, Yi-Hsiang; Kudo, Masatoshi; Rimassa, Lorenza; Marron, Thomas U; Pinato, David J; Ang, Celina
Antiangiogenic drugs currently used for colorectal cancer: What other pathways can we target to prolong responses? 1-gen-2007 Abbadessa, G; Vogiatzi, P; Rimassa, L; Claudio, Pp
Are we ready for patient-reported outcomes in hepatocellular carcinoma? 1-gen-2021 Personeni, Nicola; Rimassa, Lorenza
Assessing the impact of COVID-19 on liver cancer management (CERO-19) 1-gen-2021 Muñoz-Martínez, Sergio; Sapena, Victor; Forner, Alejandro; Nault, Jean-Charles; Sapisochin, Gonzalo; Rimassa, Lorenza; Sangro, Bruno; Bruix, Jordi; Sanduzzi-Zamparelli, Marco; Hołówko, Wacław; El Kassas, Mohamed; Mocan, Tudor; Bouattour, Mohamed; Merle, Philippe; Hoogwater, Frederik J H; Alqahtani, Saleh A; Reeves, Helen L; Pinato, David J; Giorgakis, Emmanouil; Meyer, Tim; Villadsen, Gerda Elisabeth; Wege, Henning; Salati, Massimiliano; Mínguez, Beatriz; Di Costanzo, Giovan Giuseppe; Roderburg, Christoph; Tacke, Frank; Varela, María; Galle, Peter R; Alvares-da-Silva, Mario Reis; Trojan, Jörg; Bridgewater, John; Cabibbo, Giuseppe; Toso, Christian; Lachenmayer, Anja; Casadei-Gardini, Andrea; Toyoda, Hidenori; Lüdde, Tom; Villani, Rosanna; Matilla Peña, Ana María; Guedes Leal, Cassia Regina; Ronzoni, Monica; Delgado, Manuel; Perelló, Christie; Pascual, Sonia; Lledó, José Luis; Argemi, Josepmaria; Basu, Bristi; da Fonseca, Leonardo; Acevedo, Juan; Siebenhüner, Alexander R; Braconi, Chiara; Meyers, Brandon M; Granito, Alessandro; Sala, Margarita; Rodríguez Lope, Carlos; Blaise, Lorraine; Romero-Gómez, Manuel; Piñero, Federico; Gomez, Dhanny; Mello, Vivianne; Pinheiro Alves, Rogerio Camargo; França, Alex; Branco, Fernanda; Brandi, Giovanni; Pereira, Gustavo; Coll, Susanna; Guarino, Maria; Benítez, Carlos; Anders, Maria Margarita; Bandi, Juan C; Vergara, Mercedes; Calvo, Mariona; Peck-Radosavljevic, Markus; García-Juárez, Ignacio; Cardinale, Vincenzo; Lozano, Mar; Gambato, Martina; Okolicsanyi, Stefano; Arraez, Dalia Morales; Elvevi, Alessandra; Muñoz, Alberto E; Lué, Alberto; Iavarone, Massimo; Reig, Maria
Assessment and Monitoring of Response to Systemic Treatment in Advanced Hepatocellular Carcinoma: Current Insights 1-gen-2022 Cammarota, Antonella; Zanuso, Valentina; Pressiani, Tiziana; Personeni, Nicola; Rimassa, Lorenza
Assessment of Duration and Effects of 3 vs 6 Months of Adjuvant Chemotherapy in High-Risk Stage II Colorectal Cancer: A Subgroup Analysis of the TOSCA Randomized Clinical Trial 1-gen-2020 Petrelli, F; Labianca, R; Zaniboni, A; Lonardi, S; Galli, F; Rulli, E; Rosati, G; Corallo, S; Ronzoni, M; Cardellino, Gg; Mattioli, R; Mambrini, A; Ciuffreda, L; Banzi, M; Pusceddu, V; Maiello, E; Zampino, M; Zagonel, V; Marchetti, P; Corsi, D; Rimassa, L; Cinieri, S; Sobrero, A
Assessment of HER2 status in patients with gastroesophageal adenocarcinoma treated with epirubicin-based chemotherapy: heterogeneity-related issues and prognostic implications 1-gen-2016 Personeni, N; Baretti, M; Bozzarelli, S; Spaggiari, P; Rubino, L; Tronconi, Mc; Fumagalli, U; Rosati, R; Giordano, L; Roncalli, M; Santoro, A; Rimassa, L
Assessment of letrozole and tamoxifen alone and in sequence for postmenopausal women with steroid hormone receptor-positive breast cancer: the BIG 1-98 randomised clinical trial at 8.1 years median follow-up 1-gen-2011 Regan, Mm; Neven, P; Giobbie-Hurder, A; Goldhirsch, A; Ejlertsen, B; Mauriac, L; Forbes, Jf; Smith, I; Lang, I; Wardley, A; Rabaglio, M; Price, Kn; Gelber, Rd; Coates, As; Thurlimann, B; Author, Collaborators; Rimassa, L